Search Results 8821-8830 of 42469 for oral
... oral use is acceptable. Has a known allergy/sensitivity or contraindication to BLU-5937 or any of its excipients. Previous participation in an ...
Areas of focus: Radiation therapy, Stereotactic body radiotherapy, Radiation therapy for prostate cancer, Intensity-modulated radiation... therapy, VMAT, Oral ...
... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...
Chronic obstructive pulmonary disease (COPD) requiring home oxygen therapy or chronic outpatient oral steroid use. Renal insufficiency (estimated glomerular ...
Patients must be able to swallow and retain oral medications and have no known gastrointestinal disorders likely to interfere with absorption of the study ...
"The targeted oral therapy or immunotherapy would be easier, and potentially allow and provide a quality of life for a longer time." Targeted therapy. Less ...
Use of bisphosphonates (oral or IV) or denosumab within 2 years prior to Visit 1. 9. Non-hypocalcemic seizure disorder with a history of a seizure within 26 ...
The purpose of this 12 week study is to assess the safety of oral IW-1973 when administered to patients with heart failure with preserved ejection fraction ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.